{
  "id": 17323992,
  "title": "Johnson & Johnson Just Took $7 Billion in Charges and Still Raised Its Outlook. Here's What That Tells Investors.",
  "url": "https://urgent.news/2026/10/31/johnson-johnson-just-took-7-billion-in-charges-and-still-raised-its",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-31T02:15:00.000Z",
  "source": {
    "name": "Motley Fool",
    "slug": "motley-fool",
    "url": "https://www.fool.com/investing/2026/10/30/johnson-johnson-just-took-7-billion-in-charges-and/?source=iedfolrf0000001"
  },
  "original_language": "en",
  "account": "Johnson & Johnson, a Dividend King with a 64-year streak of annual dividend increases, took a $7 billion charge in Q3 2026 due to legal expenses from a talcum powder lawsuit and other costs. Despite this, the company increased its full-year guidance, indicating resilience and focus on long-term growth. The litigation charge, while significant, may ultimately be a positive as it could streamline J&J's focus on growth. The company's revenues grew nearly 6% in the quarter, demonstrating that its core business remains strong, even if GAAP earnings per share declined roughly 96%. As a healthcare giant, J&J's products are often essential during economic downturns, suggesting potential long-term growth. Investors should consider the timing of the charge, as a bull market might overlook such issues, while a bear market could amplify investor concern. Nonetheless, Johnson & Johnson's Dividend King status and resilient business indicate it remains a strong investment choice for conservative long-term dividend investors.",
  "summary": "Johnson & Johnson's third-quarter 2026 earnings look terrible, until you dig into the story a little bit more.",
  "key_points": [
    "Johnson & Johnson charged $7 billion in Q3 2026 due to legal expenses",
    "Company raised full-year outlook despite significant legal charge",
    "J&J's revenues grew 6% quarter-over-quarter, showing strong core business"
  ],
  "editors_take": "Absorbing massive litigation costs while raising guidance signals that core business strength can insulate long-term dividend growth from the volatility of significant legal settlements and one-time charges.",
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Nasdaq Markets",
        "title": "Johnson & Johnson Just Took $7 Billion in Charges and Still Raised Its Outlook. Here's What That Tells Investors.",
        "url": "https://urgent.news/2026/10/31/johnson-johnson-just-took-7-billion-in-charges-and-still-raised-its-17331953",
        "published": "2026-10-31T02:35:00.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}